Program
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by KBI Biopharma, Inc.

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate
From KBI Biopharma, Inc.
Via Business Wire
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma, Inc. Appoints Maggie Chen as Site Head of Patriot Park Mammalian cGMP Manufacturing Facility
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma, Inc. Continues to Strengthen Leadership and Expertise With Key Executive Appointments
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing
From KBI Biopharma, Inc.
Via Business Wire
JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Appoints David Stewart as Site Head of Durham Mammalian cGMP Manufacturing Facility
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After Opening
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma, Inc. Secures Swissmedic Regulatory Establishment License for State-of-the-Art Mammalian Cell Manufacturing Facility in Geneva
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program
From KBI Biopharma, Inc.
Via Business Wire
KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease
From KBI Biopharma, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.